EP Patent

EP0624586A1 — Substituted pyrroles

Assigned to F Hoffmann La Roche AG · Expires 1994-11-17 · 31y expired

What this patent protects

The invention provides compounds of the formula    wherein R¹ represents lower alkyl, lower cycloalkyl, aryl or lower aralkyl, R² represents hydrogen, aryl or lower alkyl optionally substituted by hydroxy, acyloxy, amino, mono(lower alkyl)amino, di(lower alkyl)amino, car…

USPTO Abstract

The invention provides compounds of the formula    wherein R¹ represents lower alkyl, lower cycloalkyl, aryl or lower aralkyl, R² represents hydrogen, aryl or lower alkyl optionally substituted by hydroxy, acyloxy, amino, mono(lower alkyl)amino, di(lower alkyl)amino, carboxy, lower alkoxycarbonyl or aminocarbonyl and m and n stand for 1 or 2, as well as pharmaceutically acceptable salts of acidic compounds of formula I with bases and of basic compounds of formula I with acids, which are useful in the control or prevention of illnesses, especially in the control or prevention of inflammatory, immunological, oncological, bronchopulmonary, dermatological and cardiovascular disorders, in the treatment of asthma, AIDS or diabetic complications or for the stimulation of hair growth.

Drugs covered by this patent

Patent Metadata

Patent number
EP0624586A1
Jurisdiction
EP
Classification
Expires
1994-11-17
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.